Disease/Infection News

RSS

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study investigates the link between COVID-19 vaccines and autoimmune/neurological diseases, focusing on Guillain-Barre syndrome (GBS) risks associated with adenovirus vector vaccines.

16 Jan 2024

Why S. aureus vaccines fail: Immune system hijacked by sneaky bacteria

Staphylococcus aureus (SA) is an extremely common bacterial infection; about 30% of people have colonies of SA living in their nose.

16 Jan 2024

UK-wide COVID vaccination coverage study reveals gaps and preventable hospitalizations

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look at COVID-19 vaccine coverage of the entire UK population.

16 Jan 2024

Amsterdam UMC project aims for first effective HIV vaccine with Gates funding

Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent.

16 Jan 2024

New study shows how brain glucose affects fungal disease treatment

Metabolite-drug-fungal interactions in the fungal meningitis pathogen Cryptococcus neoformans.

16 Jan 2024

You rarely see them and might not even remember being bitten, but ticks can pose a serious threat, reveals study

The prevalence of common tick-borne diseases (TBDs) among Johnston County citizens.

16 Jan 2024

Twitter data reveals demographic insights into COVID-19 guideline compliance

A study in Scientific Reports analyzed Twitter data to identify demographic factors influencing adherence to COVID-19 public health guidelines, revealing significant variations in social mobility among different groups.

15 Jan 2024

Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Researchers investigated whether denser intrahost HIV populations had a higher incidence of coinfection and recombination.

15 Jan 2024

Ancient genomes reveal origins of multiple sclerosis risk in Europe

Researchers investigated the variables contributing to geographical heterogeneity in multiple sclerosis prevalence and the impact of genetic and environmental factors on the disease's development.

15 Jan 2024

Universal Coronavirus vaccine could save billions in U.S., new study suggests

The epidemiologic, clinical, and economic value of a universal coronavirus disease 2019 (COVID-19) vaccine.

15 Jan 2024

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.

14 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Immune dysregulation in long COVID patients uncovered in new study

Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced 'omics' and serological assays.

14 Jan 2024

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

14 Jan 2024

JN.1 variant's spread not due to enhanced immune escape, study suggests

Study finds the JN.1 variant of SARS-CoV-2 may not have increased immune escape ability compared to its predecessor BA.2.86, suggesting other factors for its rapid spread.

14 Jan 2024

Study explores intratumoral microbiota as a novel frontier in cancer research

Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.

14 Jan 2024

Leveraging nutritional interventions for effective TB control

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone.

13 Jan 2024

Swedish blood donor study reveals high prevalence of undiagnosed TBE infections

The number of infections by the tick-borne TBE virus that are not detected by health services is far higher than previously assumed.

12 Jan 2024

Human rabies in Shanghai: Epidemiological insights for improved prevention and control

Announcing a new article publication for Zoonoses journal. Rabies is a vaccine-preventable, viral zoonotic disease caused by a lyssavirus.

12 Jan 2024

Drug-resistant Candida: Study uncovers evolutionary tricks of a fungal pathogen

Global fungal infections, which affect one billion people and cause 1.5 million deaths each year, are on the rise due to the increasing number of medical treatments that heighten vulnerability.

12 Jan 2024

Disease/Infection News

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Why S. aureus vaccines fail: Immune system hijacked by sneaky bacteria

UK-wide COVID vaccination coverage study reveals gaps and preventable hospitalizations

Amsterdam UMC project aims for first effective HIV vaccine with Gates funding

New study shows how brain glucose affects fungal disease treatment

You rarely see them and might not even remember being bitten, but ticks can pose a serious threat, reveals study

Twitter data reveals demographic insights into COVID-19 guideline compliance

Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Ancient genomes reveal origins of multiple sclerosis risk in Europe

Universal Coronavirus vaccine could save billions in U.S., new study suggests

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Immune dysregulation in long COVID patients uncovered in new study

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

JN.1 variant's spread not due to enhanced immune escape, study suggests

Study explores intratumoral microbiota as a novel frontier in cancer research

Leveraging nutritional interventions for effective TB control

Swedish blood donor study reveals high prevalence of undiagnosed TBE infections

Human rabies in Shanghai: Epidemiological insights for improved prevention and control

Drug-resistant Candida: Study uncovers evolutionary tricks of a fungal pathogen

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News